Pharmaceutically Acceptable Salt Of A Cd47 Sirp Alpha Pathway

Pharmaceutically Acceptable Salt Of A Cd47 Sirp Alpha Pathway Inhibitor

Abstract: The present disclosure relates to pharmaceutically acceptable salts of compound of formula (I), particularly alkali metal salts or alkaline earth metal salts, their crystalline forms and methods of their preparation. The disclosure also relates to preparations suitable for pharmaceutical uses for treatment of various diseases or disorders mediated by CD47, particularly cancer or other proliferative diseases.

Patent Information

Application #

Filing Date

14 May 2026

Publication Number

22/2026

Publication Type

INA

Invention Field

CHEMICAL

Status

Email

Parent Application

Applicants

AURIGENE ONCOLOGY LIMITED

39/40 (P), KIADB Industrial Area, Electronics City Phase II, Karnataka Bangalore 560100

Inventors

1. SEETHARAMAIAH SETTY, Sudarshan Naremaddepalli

# 142, Pyramid Mahika, Jakkur Main Road Shivanahlli, VTC: Jakkur, PO: Yelhanka Bangalore 560064

2. SASIKUMAR, Pottayil Govindan Nair

# 5, Deccan Palms, Ananth Nagar Phase II, Electronic city post Bangalore 560100

3. ALLA, Manikantha Reddy

H. No #9, 3rd Cross, B.t.r Gardens, Kudlu Main Road, Madiwala Post Bengaluru 560068

4. CHAVAN, Rahul Baburao

Vinayaka Layout, Shantipura, Electronic City Phase II Bangalore 560100

Specification

Documents

Application Documents

#	Name	Date
1	202647061214-WIPO_PCT_DOC.pdf	2026-05-14
2	202647061214-FORM-5 [14-05-2026(online)].pdf	2026-05-14
3	202647061214-FORM 3 [14-05-2026(online)].pdf	2026-05-14
4	202647061214-FORM 18 [14-05-2026(online)].pdf	2026-05-14
5	202647061214-FORM 1 [14-05-2026(online)].pdf	2026-05-14
6	202647061214-COMPLETE SPECIFICATION [14-05-2026(online)].pdf	2026-05-14
7	202647061214-CLAIMS UNDER RULE 1 (PROVISIO) OF RULE 20 [14-05-2026(online)].pdf	2026-05-14
8	202647061214-PATENT_APPLICATION_PUBLICATION.pdf	2026-05-30
9	202647061214-Proof of Right [29-07-2026(online)].pdf	2026-07-29